Through analysis of mice with spatially and temporally restricted inactivation of Lpin1, we characterized its cell autonomous function in both white (WAT) and brown (BAT) adipocyte development and maintenance. We observed that the lipin 1 inactivation in adipocytes of aP2
A dipocytes and glial cells both rely heavily on appropriately controlled lipid metabolism: adipocytes in order to execute their role as "energy storage regulators" and glial cells in order to produce and maintain myelin membrane. A spontaneous null mutation in the Lpin1 gene present in "fatty liver dystrophy" mice (Lpin1 fld/fld ) affects both cell types, leading to a progressive demyelinating peripheral nerve neuropathy and marked lipoatrophy (27, 28, 39, 57) .
Lipin 1 is a Mg 2ϩ -dependent phosphatidic acid phosphatase (PAP1), an enzyme necessary for normal lipid biosynthesis (11, 18) . An absence of PAP1 activity in Lpin1 fld/fld mice results in dysregulated triacylglycerol biosynthesis and a subsequent accumulation of phosphatidic acid (PA) in white adipose tissue (WAT) and peripheral nerve endoneurium, which mediates part of the Lpin1 fld/fld demyelination phenotype (36) . The systemic loss of PAP1 activity and resulting impairment in triacylglycerol synthesis also clearly contribute to the lipodystrophy in Lpin1 fld/fld mice (13) . Recently, we described a rat model with a mutated Lpin1 protein (Lpin1 1Hubr ) lacking PAP1 activity that developed hypomyelination and mild lipodystrophy (34) . On the contrary, overexpression of Lpin1 in adipose tissue promotes obesity when mice are fed a high-fat diet (40) . Importantly, reduced levels of Lpin1 mRNA were observed in subjects with obesity, insulin resistance and HIV-associated lipodystrophy (29, 53, 56) , while mutations in LPIN1 were recently found to result in recurrent childhood episodes of myoglobinuria (33, 64) . These in vivo observations, together with the data showing that lipin 1 is involved in adipogenesis in vitro (25, 38, 42) , suggest that lipin 1 plays an important role in adipocyte development and function. But in vivo adipose tissue-specific inactivation of lipin 1 has not been explored so far.
In order to characterize the cell autonomous function of lipin 1 in adipocyte maturation, maintenance, and survival, we selectively deleted Lpin1 in developing and mature adipocytes through the use of time-and tissue-specific gene ablation. ] adipocyte-selective Lpin1 knockout model mice) established that a cell autonomous role of lipin 1 is crucial for adipocyte maintenance and survival. We further demonstrated that intracellular PA accumulation inhibits adipocyte differentiation and contributes to the adipocyte defects observed in aP2
Cre/ϩ / Lpin1 fEx2-3/fEx2-3 mice. Importantly, we also reveal that Lpin1 expression is induced by cold exposure and contributes to thermogenic activation of brown adipose tissue (BAT). Together, these data provide new insight into the role of lipin 1 in adipocyte tissue development and function.
, aP2 ϩ/ϩ /Lpin1 fEx2-3/ϩ , and aP2
Cre/ϩ /Lpin1 fEx2-3/ϩ genotypes were all referred to as "aP2 ϩ/ϩ " controls. aP2
Cre/ϩ /Lpin1 fEx2-3/fEx2-3 and aP2 CreERT2/ϩ /Lpin1 fEx2-3/fEx2-3 pups were obtained at the expected Mendelian frequency. Experiments were performed in accordance with the legal requirements of the University of Lausanne and of the Canton of Vaud (Switzerland).
Generation of aP2
Cre/؉
/Lpin1
fEx2-3/fEx2-3 and aP2
CreERT2/؉ / Lpin1 fEx2-3/fEx2-3 mice. In order to generate mice with the Lpin1 gene selectively inactivated only in adipocytes, the Lpin1 fEx2-3/fEx2-3 mice were crossed with aP2
Cre or aP2 CreERT2 transgenic mice (19, 22 CreERT2/ϩ /Lpin1 fEx2-3/fEx2-3 ). The LpCond F (F1) and LpCond R primers were used for genotyping of the generated mice, amplifying a 780-bp product from the Lpin1 fEx2-3 allele and a 740-bp product from the Lpin1 ϩ allele. The aP2-CreF and aP2-CreR primer set amplifying the 492-bp PCR product was used for the detection of the aP2 Cre allele. The combination of primers F1, F2, and R1 was used to detect Lpin1 ⌬Ex2-3 with deleted exons 2 and 3 (Fig. 1A) . Detailed PCR conditions are available upon request. All primer sequences are in Table S1 in the supplemental material.
BrdU incorporation assay. Four-month-old mice were injected intraperitoneally daily for 6 consecutive days with 100 g of BrdU per gram of body weight. The epididymal and subcutaneous white adipose tissues (WAT) were dissected, fixed in 4% paraformaldehyde for 24 h, washed in PBS, and embedded in paraffin. Paraffin sections were denatured with 2 N HCl for 20 min at 37°C and neutralized in 0.1 M sodium borate (pH 8.5) for 10 min. Sections were incubated with rat anti-BrdU (at a 1:200 dilution; Abcam) in 0.3% Triton X-100 overnight at 4°C. The next day, the sections were incubated with anti-rat secondary antibody conjugated to Alexa Fluor 594 (at a 1:200 dilution; Invitrogen) and visualized with fluorescence microscopy. The nuclei were counterstained with 4=,6-diamidino-2-phenylindole (DAPI).
Tamoxifen treatment. Four-week-old aP2 CreERT2/ϩ /Lpin1 fEx2-3/fEx2-3
and aP2 ϩ/ϩ /Lpin1 fEx2-3/fEx2-3 littermates were injected intraperitoneally once a day with vehicle (sunflower oil) or with 1 mg of tamoxifen (Tamox) in 100 l of sunflower oil for 5 consecutive days.
Cold exposure. Mice were individually housed and exposed to either 24°C or 4°C. The colonic temperature was measured with the rectal Bioseb thermometer.
High-fat-diet treatment. Under normal conditions, mice were fed a standard laboratory chow (regular diet, chow; 3.225 kcal/kg [4.9% calories from fat]; Kliba Nafag, Kaiseraugst, Switzerland). The high-fat diet (HF) study was carried out for 5 weeks with a chow containing 4.057 kcal/kg (60% calories from fat; Research Diets, New Brunswick, NJ).
Glucose tolerance test (GTT) and ITT. Male mice (ages 3 to 4 months) were fasted overnight. Glucose levels were determined 30 min before glucose injection. After an intraperitoneal (i.p.) injection of 1.5 g of glucose/kg body weight, glucose levels were determined with a OneTouch Ultra glucometer (Lifescan) at 0, 15, 30, 60, 90, and 120 min using blood from the tail vain. For the insulin tolerance test (ITT), 3-to 4-month-old randomly fed male mice were used. After an i.p. injection of 0.75 U of insulin/kg body weight (Humulin R; Eli Lilly), glucose levels were determined at 0, 15, 30, 60, 90, and 120 min as described above, and areas under the curve (AUC) were calculated.
Biochemical assays. Blood was collected in nonfasted mice from their tail or retro-orbital vein. Glucose was measured from whole blood using a Glucometer Elite meter (Bayer). Serum insulin was measured by using an enzyme-linked immunosorbent assay (ELISA) kit (Millipore Corporation, Billerica, MA). Total cholesterol, high-density lipoprotein (HDL) cholesterol, low-density lipoprotein (LDL) cholesterol, triacylglycerols, free fatty acids (FFA), and lipase were measured with a Hitachi 902 fully automated clinical analyzer (Roche Diagnostics India, Mumbai, India).
Quantitative PCR. Total RNA from sciatic nerve (peri/epineurium and endoneurium) and WAT was isolated using the Qiagen RNeasy lipid tissue kit (Qiagen), following the manufacturer's instructions. Total RNA from muscle, brain, and liver was isolated in TRIzol (Invitrogen) reagent and purified using the RNeasy kit (Qiagen). RNA quality was verified by agarose gel and/or by the Qiaxcel capillary electrophoresis device (Qiagen), and the concentration was determined by using an ND-1000 spectrophotometer (NanoDrop). Total RNA (250 to 500 ng) was subjected to reverse transcription using the SuperScript III First-Strand synthesis system for reverse transcription-PCR (RT-PCR) (Invitrogen), following the manufacturer's instructions. The resulting cDNA was used as a template for relative quantitative real-time PCR as described previously (36) . Results were normalized using the reference gene Ubiquitin. See Table S1 in the supplemental material for a complete list of oligonucleotides used for RNA quantitations.
Western blotting. Tissues were lysed in ice-cold lysis buffer (20 mM Na 2 H 2 PO 4 , 250 mM NaCl, Triton X-100 [1%], and SDS [0.1%]) supplemented with Complete protease inhibitor mix (Roche). Protein levels were quantified using the Bio-Rad protein assay with bovine serum albumin (BSA) as a standard. Equal amounts of protein extracts were resolved by 10% SDS-PAGE and electrotransferred onto a polyvinylidene difluoride (PVDF) membrane (Amersham Biosciences). Blots were blocked in Tris-buffered saline containing 0.1% Tween (TBS-T) supplemented with 4% milk powder and subsequently incubated overnight at 4°C in the same buffer supplemented with antibodies against Erk1/2, phosphorylated Erk1/2 (P-Erk1/2), Akt, phosphorylated Akt (P-Akt), and tubulin (Cell Signaling). After washing in TBS-T, blots were exposed to the appropriate horseradish peroxidase-conjugated secondary antibodies (Dako) in TBS-T for 1 h at room temperature. Finally, the blots were developed using ECL reagents (Pierce) and Kodak Scientific Imaging films (Kodak).
WAT fractionation. Adipocyte fractions of WAT were isolated by using a modification of a previously described protocol (26) . Epididymal fat pads were excised from adult mice and placed in Hanks balanced salt solution (HBSS) (Gibco; Invitrogen) containing 1% HEPES and 3% BSA. Fat pads were finely minced, washed twice in DMEM-F-12 (Gibco; Invitrogen), and placed in DMEM-F-12 containing 1 mg/ml collagenase (type I; Worthington) at 37°C for 30 min with gentle agitation. The cell suspension was filtered through a 250-m nylon filter (Nitex; Safar America), and the filtrate was centrifuged at 500 ϫ g for 5 min at room temperature to separate the pellet containing the stromal vascular fraction (SVF) from the floating adipocytes. Total RNA was extracted from floating adipocytes using the Qiagen RNeasy lipid tissue kit (Qiagen), following the manufacturer's instructions.
PAP activity measurement. Tissue samples were disrupted using a Dounce homogenizer at 4°C in 50 mM Tris-HCl (pH 7.5) buffer containing 0.25 M sucrose, 1 mM EDTA, 10 mM ␤-mercaptoethanol, 1 mM benzamidine, 0.5 mM PMSF, and 5 g/ml of aprotinin, leupeptin, and pepstatin. The lysed cells were centrifuged at 1,000 ϫ g for 10 min at 4°C, and the supernatant was used as cell extract. Total PAP activity (Mg 2ϩ dependent and Mg 2ϩ independent) was measured at 37°C for 20 min in the reaction mixture (total volume of 100 l) containing 50 mM Tris-HCl (pH 7.5), 1 mM MgCl 2 , 10 mM ␤-mercaptoethanol, 0.2 mM [ 32 P]PA (5,000 cpm/nmol), 2 mM Triton X-100, and enzyme protein (6 (36) . The F1, F2, and R1 primers were used for PCR amplification of genomic DNA. (B) Lpin1 deletion was absent in control animals (aP2 ϩ/ϩ ) and was observed in white adipose tissue (WAT) and the perineurial/epineurial (P/E) compartment of sciatic nerves but not in the endoneurium (Endo) from aP2
Cre/ϩ /Lpin1 fEx2-3/fEx2-3 (aP2 Cre/ϩ ) mice. PCR amplification, using a combination of the primers F1, F2, and R1, was used to detect the floxed allele (Lpin1 fEx2-3 ; 1,449 bp) and the Lpin1-null allele (Lpin1 ⌬Ex2-3 ; 1,074 bp). (C) Quantitative PCR showed that Lpin1 expression is decreased in epididymal (Epi) and subcutaneous (Sc) WAT whereas its expression in heart and liver was not affected in aP2
Cre/ϩ mice (n ϭ 3; ‫,ء‬ P Ͻ 0.001). (D) Quantitative PCR showed that Lpin1 expression is almost abolished in purified aP2
Cre/ϩ adipocytes (n ϭ 4; ‫,ء‬ P Ͻ 0.05). (E) PAP1 activity was substantially decreased in WAT, but not in the liver, of aP2
Cre/ϩ mice compared to results for control aP2 ϩ/ϩ mice. However, no significant difference in both WAT and liver PAP2 activity was observed between genotypes (n ϭ 8; ‫,ء‬ P Ͻ 0.001).
zyme activity from total enzyme activity. A unit of PAP activity was defined as the amount of enzyme that catalyzed the formation of 1 nmol of product/min. Specific activity was expressed as units/mg protein. The average standard deviation of the assays was Ϯ5%. The reactions were linear with time and protein concentration.
PA quantitation. PA was quantified as previously described (36) . Tissues (the endoneurium from two nerves and ϳ300 mg of adipose tissue) were homogenized in 1.5 ml of PBS containing 0.5 mM Na orthovanadate (Sigma) and extracted twice with 1 volume of butanol. After evaporation, phospholipids were solubilized in 1 ml of PBS containing 1% BSA and 0.5 mM Na orthovanadate. An aliquot of the solution was incubated for 90 min at 37°C in the presence or not of bovine pancreatic PLA2 (3.8 U/ml; Sigma). At the end of the incubation, phospholipids were extracted with butanol and dried, and LPA was quantified. The amount of PA corresponds to the amount of LPA detected after treatment with PLA2 after the subtraction of the amount of LPA detected without PLA2 treatment. The assay was performed in triplicate for each sample.
WAT morphology. After measuring body weight, the left and right epididymal WAT fat pads were harvested and weighed. Subsequently, WAT samples were collected in 4% formaldehyde, rotated overnight at 4°C, rinsed twice with 100% ethanol for 2 h, left in xylene overnight at room temperature, and embedded in paraffin. The tissue was then cut in 5-m sections and stained with hematoxylin and eosin. Average adipocyte cell diameters were measured using the NIH ImageJ software program.
RESULTS
Adipocyte-selective Lpin1 inactivation. In order to uncover the function of lipin 1 in adipocytes, we crossed previously generated mice carrying loxP sites flanking the second and third Lpin1 exons (Lpin1 fEx2-3/fEx2-3 ) (36) with aP2 Cre transgenic mice (Fig. 1A) . aP2
Cre -mediated deletion of exons 2 and 3 is predicted to result in loss of lipin 1 function in both brown and white adipose tissue (BAT and WAT, respectively), and this strategy is expected to delete Lpin1 throughout the formation of fat depots, thus not impairing adipocyte differentiation (19 and aP2 Cre/ϩ /Lpin1 fEx2-3/ϩ ) mice were born at the predicted Mendelian frequencies, produced normal progeny and appeared overall phenotypically normal. To examine Cre-mediated recombination efficiency, genomic DNA isolated from WAT, perineurium/ epineurium, and endoneurium compartments of sciatic nerve derived from aP2
Cre/ϩ /Lp fEx2-3/fEx2-3 and control mice was subjected to PCR. Control mice did not show any detectable level of exon 2-exon 3 recombination. However, in the Cre-expressing mice, we detected a significant level of exon 2 and 3 deletion, specifically in adipocyte-rich peri/epineurium and WAT (Fig. 1B) . As expected, aP2-driven Cre expression was high in WAT, detected in the heart, while no expression could be detected in the liver (see Fig. S1 in the supplemental material). However, the Cre expression resulted in a substantial decrease of Lpin1 mRNA expression only in WAT and not in the heart or liver (Fig. 1C) . Importantly, WAT fractionation further indicated that Lpin1 expression in purified adipocytes derived from aP2
Cre/ϩ / Lp fEx2-3/fEx2-3 animals was reduced by approximately 80% compared to that for control mice (Fig. 1D) . The above-mentioned results demonstrate that Lpin1 expression was efficiently disrupted in adipocytes. Since the observed reduction of Lpin1 expression should lead to a decrease in phosphatidic acid phosphatase (PAP1) activity (18), we measured PAP activity in WAT and liver tissue of aP2
Cre/ϩ /Lp fEx2-3/fEx2-3 and control mice and observed reduced PAP1 activity specifically in WAT (Fig. 1E) . Interestingly, the level of PAP2 (lipid phosphate phosphatase 2) activity, which has a Mg 2ϩ -independent phosphatase activity (46), was not affected in either WAT or liver derived from aP2
Cre/ϩ / Lp fEx2-3/fEx2-3 mice (Fig. 1E ).
Functional consequences of missing lipin 1 in WAT. Although the body weight of aP2
Cre/ϩ /Lp fEx2-3/fEx2-3 mice was not significantly different from that of control mice on a regular diet, at 3 months of age the weight of their epididymal WAT (eWAT) fat pads was substantially lower despite normal food intake (0.19 Ϯ 0.07 g [n ϭ 16] versus 0.53 Ϯ 0.47 g [n ϭ 13]; P ϭ 0.007) ( Fig Cre/ϩ /Lp fEx2-3/fEx2-3 mice, numerous multilocular adipocytes were labeled as well, strongly suggesting that in aP2
Cre/ϩ / Lp fEx2-3/fEx2-3 mice the multilocular cells derive from a mitotic proliferation of precursors ( Fig. 2E and F) . Albeit less frequently, this phenotype was also seen in HFD-treated animals.
Because aP2
Cre/ϩ /Lp fEx2-3/fEx2-3 adipocytes revealed a reduction in cell size, we examined their lipid content in liver and skeletal muscle by Oil Red O staining. While no detectable changes were observed in skeletal muscle, aP2
Cre/ϩ /Lp fEx2-3/fEx2-3 mice developed a moderate fatty liver phenotype (see Fig. S4A in the supplemental material; also data not shown).
We next examined the effects of loss of Lpin1 expression on metabolic parameters. As previously observed for Lpin1 fld/fld mice (45), aP2
Cre/ϩ /Lp fEx2-3/fEx2-3 mice displayed a partial metabolic sequel of lipodystrophy. Plasma insulin levels were significantly higher in aP2
Cre/ϩ /Lp fEx2-3/fEx2-3 mice on regular diet or HFD, whereas glucose, cholesterol, triacylglycerols, free fatty acid (FFA), and lipase levels did not differ significantly between aP2
Cre/ϩ / Lp fEx2-3/fEx2-3 and control mice (Table 1) . Lipodystrophy is often accompanied by insulin resistance (50) 
aP2
Cre/ϩ /Lp fEx2-3/fEx2-3 mice on a regular diet showed a slight but significant decrease in three markers of adipocyte maturation: fatty acid binding protein 4 (encoded by aP2/Fabp4), diacylglycerol acyltransferase 1 (encoded by Dgat1), which catalyzes the final step of the triacylglycerols synthesis (63) , and Cd36, a facilitator of long-chain fatty acid transport (1, 10) (Fig. 3A) . None of the tested markers were significantly affected by HFD feeding conditions (Fig. 3B) . However, on chow we detected an increased level of expression of the macrophage markers F4/80 and CD68 in eWAT derived from aP2
Cre/ϩ /Lp fEx2-3/fEx2-3 mice (see Fig. S4B in the supplemental material).
To further study the role of lipin 1 in adipocyte maturation, mouse embryonic fibroblasts (MEFs) were derived from aP2 ϩ/ϩ / Lp fEx2-3/fEx2-3 and aP2 Cre/ϩ /Lp fEx2-3/fEx2-3 embryos that were littermates. MEFs were induced to differentiate into adipocytes in vitro using a standard adipogenic induction protocol, and Oil Red O staining was performed to monitor their intracellular lipid accumulation. Importantly, the Cre expression detectable in aP2
Cre/ϩ cells from day 4 resulted in a substantial decrease in their Lpin1 mRNA expression (see Fig. S5 in the supplemental material). In cells of both genotypes, oil droplets became visible on day 4 and the number of droplet-positive cells was constant until day 6 (Fig. 3C) . However, at day 8, as judged by cell morphology and Oil Red O staining, the lipid droplets appeared smaller in aP2
Cre/ϩ /Lp fEx2-3/fEx2-3 MEFs, and this phenotype became more obvious at day 10. Bright-field images also revealed an accumulation of particular cell structures in aP2
Cre/ϩ /Lp fEx2-3/fEx2-3 MEFs (Fig. 3D) . Coimmunostaining with adipose differentiation-related protein (ADFP) and Bodipy staining of neutral lipids revealed that these structures represent very small lipid droplets in aP2
Cre/ϩ /Lp fEx2-3/fEx2-3 MEFs (Fig. 3D , panels iv and v). In contrast, control aP2 ϩ/ϩ /Lp fEx2-3/fEx2-3 MEFs showed enhanced differentiation with sustained lipid accumulation and characteristic morphological features of mature adipocytes, including fewer and larger lipid droplets (Fig. 3D, panel (Fig. 3E) . Interestingly, we also observed reduced expression of two lipolytic genes, hormone-sensitive lipase (HSL) and adipose triglyceride lipase (ATGL) (Fig. 3E) . Overall, these results suggest that the multilocular cells are preadipocytes that failed to finish their differentiation and indicate that sustained Lpin1 expression is crucial for adipocyte maturation.
Lipin 1 plays critical role in mature white adipocytes. To specifically study the consequences of Lpin1 inactivation in mature adipocytes, we crossed Lpin1 fEx2-3/fEx2-3 mice with aP2
Cre-ERT2 transgenic mice expressing a ligand-dependent fusion protein of Cre recombinase with a mutated ligand-binding domain of the human estrogen receptor ␣ in white and brown adipocytes (23) . Since the Cre-ER T2 recombinase activity is ligand dependent (22) , the ablation of Lpin1 in adipocytes of adult mice occurs only after treatment of aP2
Cre-ERT2/ϩ /Lp fEx2-3/fEx2-3 transgenic mice with tamoxifen (Tamox). One-month-old mutant (aP2
Cre-ERT2/ϩ /Lp ϩ/fEx2-3 , and aP2
Cre-ERT2/ϩ /Lp ϩ/ϩ ) mice were injected with Tamox for 5 consecutive days (D0 to D4) (Fig. 4A ) and characterized at days D7, D22, and D60 postinjection. PCR analysis revealed significant levels of exon 2 and 3 deletion at D7, which was less clear at D22 and D60 (Fig. 4B) . The body weight of aP2
Cre-ERT2/ϩ /Lp fEx2-3/fEx2-3 mice was not different from that of control mice (see Fig. S6A in the supplemental material). However, at D7 and D22, the weight of eWAT fat pads was substantially lower in mutant animals despite normal food intake, and this phenotype disappeared at D60 ( eWAT was composed of characteristic large, unilocular triglyceride-filled adipocytes, histology of eWAT from aP2 Cre-ERT2/ϩ / Lp fEx2-3/fEx2-3 mice at D7 and D22 revealed a strong reduction of unilocular adipocyte size and frequent areas of multilocular cell clusters ( Fig. 4D ; see also Fig. S6C and D) . Importantly, at D60, the multilocular cells were rarely observed in eWAT from aP2
Cre-ERT2/ϩ /Lp fEx2-3/fEx2-3 mice, indicating that a mechanism of adipose tissue recovery occurred between D22 and D60. In addition, as observed for the aP2
Cre/ϩ /Lp fEx2-3/fEx2-3 mice, at D60 the mean number of cells per field was significantly higher in aP2
Cre-ERT2/ϩ /Lp fEx2-3/fEx2-3 eWAT than in the control aP2 ϩ/ϩ / Lp fEx2-3/fEx2-3 eWAT, confirming that the reduced tissue mass reflects a reduction in cell size (see Fig. S6C ). We further evaluated the adipocyte phenotype by measuring the level of expression of selected adipocyte markers in purified epididymal adipocytes (Fig. 4E) . Surprisingly, while Lpin1 mRNA levels were decreased by approximately 80% at D7 and 60% at D22, no significant difference was observed at D60, reflecting the adipocyte recovery in aP2
Cre-ERT2/ϩ /Lp fEx2-3/fEx2-3 mice. We observed a similar expression pattern for aP2/Fabp4, HSL, and ATGL genes (Fig. 4E) . The eWAT from aP2
Cre-ERT2/ϩ /Lp fEx2-3/fEx2-3 mice also exhibited reduced expression levels of two antiapoptotic factors, Bcl2 and Bcl2l1 (20) , potentially reflecting an increase in adipocyte cell death (Fig. 4E) . In addition, we found that the mRNA level of Wisp2, an adipocyte precursor cell marker (8) , is elevated only at D7 in eWAT from aP2
Cre-ERT2/ϩ /Lp fEx2-3/fEx2-3 mice. Interestingly, we also observed a reduced level of mRNA expression of two macrophage markers, F4/80 and CD68, in eWAT from aP2
Cre-ERT2/ϩ / Lp fEx2-3/fEx2-3 mice at D60 compared to that at D7 and D22 (Fig. 4F) . Collectively, these results indicate that Lpin1 inactivation in mature adipocytes in aP2
Cre-ERT2/ϩ /Lp fEx2-3/fEx2-3 mice led to a temporally restricted lipodystrophy associated with a multilocular adipocyte phenotype, expansion of adipocyte precursor pools, and inflammation. Thus, our histological and gene expression data suggest that Lpin1-inactivated mature adipocytes were progressively replaced by new Lpin1-positive adipocytes.
Inactivation of Lpin1 in mature adipocytes protects aP2
Cre-ERT2/؉ /Lp fEx2-3/fEx2-3 mice against high-fat-diet-induced obesity. To evaluate the functional consequences of Lpin1 inactivation in mature WAT, aP2
Cre-ERT2/ϩ /Lp fEx2-3/fEx2-3 mice were provided with an HFD between D60 and D130 (Fig. 4A) . While weight gained by aP2 ϩ/ϩ /Lp fEx2-3/fEx2-3 mice was substantial (ϳ36% increase from the baseline after 10 weeks of HFD; n ϭ 7), it was considerably less important in aP2
Cre-ERT2/ϩ /Lp fEx2-3/fEx2-3 mice (ϳ15%; n ϭ 6) (Fig. 5A ) despite having equal food intake (data not shown). The decreased weight gain of aP2
Cre-ERT2/ϩ / Lp fEx2-3/fEx2-3 mice was reflected by lower eWAT weight and lesssubstantial increases in eWAT adipocyte size (Fig. 5B to D nied by an increased infiltration of macrophages in WAT and increased steatosis in the liver, both considerably less detectable in aP2
Cre-ERT2/ϩ /Lp fEx2-3/fEx2-3 mice (Fig. 5C ). This observation is consistent with increased levels of mRNA expression of two macrophage markers, F4/80 and CD68, in eWAT of aP2 ϩ/ϩ / Lp fEx2-3/fEx2-3 compared to that of aP2
Cre-ERT2/ϩ /Lp fEx2-3/fEx2-3 mice at D130 on the HFD (Fig. 5E ). Despite increased levels of plasma insulin at D130 in aP2 ϩ/ϩ /Lp fEx2-3/fEx2-3 mice (Fig. 5F ), no statistically significant differences were found between aP2 ϩ/ϩ / Lp fEx2-3/fEx2-3 and aP2
Cre-ERT2/ϩ /Lp fEx2-3/fEx2-3 mice when we performed an ipGTT and ITT, indicating that glucose and insulin metabolism is normal in aP2
Cre-ERT2/ϩ /Lp fEx2-3/fEx2-3 mice at D130 on the HFD (Fig. 5G and H (36) . These data suggest that PA might also play a role in adipocyte fate determination. Therefore, we assessed the level of PA in WAT isolated from aP2
Cre/ϩ /Lp fEx2-3/fEx2-3 mice and found that the PA level was increased 3-fold compared to that for control mice (Fig.  6A) . To evaluate the possible role of PA in adipocyte differentiation, we induced 3T3-L1 cells to differentiate in the presence or absence of PA and U0126, a selective inhibitor of the MEK-Erk pathway. Oil Red O staining revealed that PA prevented differentiation of 3T3-L1 cells into adipocytes (Fig. 6B) . This observation was confirmed by gene expression analysis of adipocyte-specific genes, such as Lpin1, Cd36, Fabp4, Fasn, and Pparg (Fig. 6C) . Interestingly, inhibition of adipocyte differentiation by PA was rescued by the coadministration of U0126 (Fig. 6B and C) . We confirmed the antiadipogenic activity of PA in Simpson-GolabiBehmel syndrome (SGBS) cells, a human preadipocyte cell line (59) . When SGBS cells were differentiated for 7 days in the presence of 50 M PA in an adipogenic medium, a striking reduction in triacylglycerol droplet accumulation was observed (Fig. 6D) . This effect was accompanied by a strong reduction in Fabp4 expression (Fig. 6E) . Although an increase in exogenous PA clearly Fig. 6F and G) . Importantly, we observed that the overexpression of lipin 1␤ was able to rescue the effect of PA on the differentiation of 3T3-L1 cells ( Fig. 6H and I ). We next evaluated whether PA also affects mature adipocyte maintenance. MEFs were induced to differentiate into adipocytes and treated with 100 M PA between D6 and D12 (see Fig. S8A in the supple- 
05). (G and H) Blood glucose concentrations during an intraperitoneal glucose tolerance test (G) or an insulin tolerance test (H) in P160 aP2
ϩ/ϩ and aP2 Cre-ERT2/ϩ mice maintained on an HFD. Data represent means Ϯ SD (n ϭ 7 or 8). mental material). Surprisingly, the number and growth of oil droplets were not disturbed, indicating that PA is not affecting mature adipocytes (see Fig. S8B ). Altogether, these data suggest that the potent inhibitory effect of PA mostly plays a role in the early stage of adipocyte differentiation.
Recent reports suggested that the biological effects of exogenous PA are predominantly mediated by its conversion to lysophosphatidic acid (LPA), which subsequently activates the LPA receptor endothelial differentiation gene 2 (Edg-2) (62). Importantly, preadipocytes express the LPA receptor, and LPA increases preadipocyte proliferation (51) . To evaluate whether the inhibitory effect of PA on 3T3-L1 cells was also mediated via LPA receptor activation, we pretreated the 3T3-L1 cells with pertussis toxin, an inhibitor of G i/o protein-coupled receptors (24) . LPA-induced Erk1/2 phosphorylation was completely suppressed by treatment with pertussis toxin, whereas PA-induced Erk1/2 phosphorylation resisted this treatment in 3T3-L1 cells (Fig. 7A) . These observations demonstrate that PA-induced Erk1/2 phosphorylation is not dependent on LPA receptor activation. Finally, in order to demonstrate the specificity of MEK-Erk signaling pathway activation by PA, we treated 3T3-L1 cells with either 1, 10, and 100 M PA or 100 M propranolol, the PAP1 function inhibitor, and observed a significant increase in the phosphorylation of Erk1/2, while Akt phosphorylation was not significantly affected (Fig. 7B) . Together, these results suggest that intracellular PA accumulation inhibits adipocyte differentiation through the MEK-Erk pathway.
BAT development and function also require lipin 1 function. To determine the consequences of adipocyte-selective Lpin1 disruption for BAT development in aP2
Cre/ϩ /Lp fEx2-3/fEx2-3 mice, we evaluated its structure in mutant and control mice. Macroscopic examination revealed a marked paucity of BAT in aP2
Cre/ϩ / Lp fEx2-3/fEx2-3 mice (Fig. 8A ). While BAT weight was similar between aP2 ϩ/ϩ /Lp fEx2-3/fEx2-3 and aP2 Cre/ϩ /Lp fEx2-3/fEx2-3 mice at postnatal day 10 (P10), it was considerably reduced in aP2
Cre/ϩ / Lp fEx2-3/fEx2-3 mice at P90 (ϳ66% reduction; n ϭ 6) (Fig. 8B) . Active wild-type BAT consists of mitochondrion-rich eosinophilic cells containing multiple lipid droplets. In contrast, BAT derived from 3-month-old aP2
Cre/ϩ /Lp fEx2-3/fEx2-3 mice showed sparse eosinophilic staining, large unilocular vacuoles, and peripheral nuclei, resembling immature white adipocytes (Fig. 8C) . To determine whether Lpin1 ablation affected BAT function, aP2
Cre/ϩ /Lp fEx2-3/fEx2-3 and aP2 ϩ/ϩ /Lp fEx2-3/fEx2-3 mice were exposed to cold temperatures. In contrast to control mice, which were able to maintain a correct body temperature, aP2
Cre/ϩ / Lp fEx2-3/fEx2-3 mice became hypothermic at 4°C (Fig. 8D) . At 24°C, the expression of uncoupling protein 1 (encoded by Ucp1), the or LPA or pretreated with 50 ng/ml of pertussis toxin before addition of the indicated concentration of phosphatidic acid (PA ϩ PTX) or lysophosphatidic acid (LPA ϩ PTX). The activation of Erk1/2 was evaluated by Western blotting using a specific antibody recognizing its phosphorylated form (P-Erk1/2). An antibody against Erk1/2 revealed its total amount in the lysate. (B) 3T3-L1 cells were treated for 1 h with increasing concentrations (0, 1, 10, and 100 M) of PA or 100 M of propranolol (Prop). Activation of Erk1/2 and Akt was evaluated by specific antibodies recognizing their phosphorylated forms (P-Erk1/2 and P-Akt). molecular marker which distinguishes BAT from WAT, as well as PGC1-␣ and Ppara, was strongly reduced in aP2
Cre/ϩ / Lp fEx2-3/fEx2-3 BAT compared to that for controls (Fig. 8E) . PPAR␣ is an important regulator of fatty acid oxidation (31) . We therefore also examined the expression of selected PPAR␣ target genes in the BAT of aP2
Cre/ϩ /Lp fEx2-3/fEx2-3 mice. We found that mRNA levels of several ␤-oxidation enzymes, including acyl coenzyme A (acyl-CoA) oxidase 1 (encoded by Acox1) (ACO), carnitine palmitoyltransferase 1 (encoded by Cpt1b) (CPT1b), long-chain acyl-CoA synthetase (encoded by Acsl1) (LACS), and mediumchain acyl-CoA dehydrogenase (encoded by Acadm) (MCAD), were markedly reduced in aP2
Cre/ϩ /Lp fEx2-3/fEx2-3 BAT compared to those for controls (Fig. 8E) . These findings indicate that the capacity for ␤-oxidation is reduced in aP2
Cre/ϩ /Lp fEx2-3/fEx2-3 BAT. As expected, after 12 h of exposure to 4°C, we observed a strong induction of Ucp1 and PGC1-␣ expression in control aP2 ϩ/ϩ / Lp fEx2-3/fEx2-3 mice. However, this upregulation was less pronounced in aP2
Cre/ϩ /Lp fEx2-3/fEx2-3 mice (Fig. 8E) . Surprisingly, we observed that thermogenic activation also induces Lpin1 gene expression in aP2 ϩ/ϩ /Lp fEx2-3/fEx2-3 mice (Fig. 8E) concomitant with a role of lipin 1 in BAT function. To explore the effect of lipin 1 on BAT differentiation, we generated mouse embryonic fibroblast (MEF) cells overexpressing lipin 1␤ using a lentiviral approach. We observed that the expression of Ucp1, PGC-1␣, Elovl3 (elongation of very-long-chain fatty acid 3 [Cig30], a crucial regulator of lipid synthesis in BAT [54, 61] ), Acox1, Cpt1b, Acsl1, and Acadm was higher in differentiated MEFs overexpressing lipin 1␤ (Fig. 8F) . Together, these observations indicate that lipin 1 plays a crucial role in BAT function and differentiation.
Lipin 1 is required in mature brown adipocytes. To explore the consequences of Lpin1 inactivation in mature brown adipocytes, we characterized intracapsular BAT (iBAT) in aP2 Cre-ERT2/ϩ /Lp fEx2-3/fEx2-3 transgenic mice treated with Tamox (Fig. 4A ). As observed with WAT, Tamox treatment induced significant decreases in iBAT weight in aP2
Cre-ERT2/ϩ /Lp fEx2-3/fEx2-3 mice at D7 (ϳ30% reduction) and D22 (ϳ52% reduction). Importantly, while still detectable, the difference in iBAT weight between aP2
Cre-ERT2/ϩ /Lp fEx2-3/fEx2-3 and aP2 ϩ/ϩ /Lp fEx2-3/fEx2-3 mice was less pronounced (ϳ20% reduction) at D60 (Fig. 9A) . We completed these data by assessing Lpin1, Cre, and selected adipocyte marker expression in iBAT from aP2
Cre-ERT2/ϩ /Lp fEx2-3/fEx2-3 mice and control mice at D7, D22, and D60 (Fig. 9B) . As expected, Lpin1 mRNA levels were decreased by ϳ50% at D7 and ϳ32% at D22 in iBAT from aP2
Cre-ERT2/ϩ /Lp fEx2-3/fEx2-3 mice. However, no significant difference was observed at D60, reflecting a level of brown adipocyte recovery. Importantly, at D7, reduced Lpin1 expression was associated with decreased expression of Ucp1, PGC1-␣, Ppara, and Pparg, and as with Lpin1, the expression of these markers was normalized at D60. In agreement with these data, at D7 and D22, the histology of iBAT from aP2
Cre-ERT2/ϩ / Lp fEx2-3/fEx2-3 mice revealed much larger lipid droplets than for control mice. However, at D60, these abnormalities disappeared (Fig. 9C) . Interestingly, similar to the situation observed in WAT, when we challenged the mice with an HFD (from D60 to D130), we observed that despite regular Lpin1 and Ucp1 expression, aP2
Cre/ϩ /Lp fEx2-3/fEx2-3 BAT had a reduced capacity to accumulate lipids (see Fig. S9 in the supplemental material) . Collectively, these data revealed that lipin 1 is required for mature brown adipocyte maintenance and function. 
DISCUSSION
By generating and characterizing adipocyte-selective Lpin1 knockout mice, we demonstrated a crucial cell autonomous role for lipin 1 in adipocyte function and maintenance. To study the adipocyte-selective role of lipin 1, we used two aP2-Cre lines: aP2-Cre (19) and aP2-Cre-ERT2 (22) , which were bred with previously characterized floxed Lpin1 mice (36) . We showed that both aP2-Cre lines display high efficiency of Cre-mediated recombination in adipocytes. However, we also observed aP2-Cre expression in additional tissues (e.g., heart). These data confirm reports showing aP2-Cre expression in macrophages, ganglia of the peripheral nervous system, neurons of central nervous system, and certain progenitor cells during embryonic development (30, 32, 55) . However, the parallel use of an inducible aP2-Cre-ERT2 line that expresses a tamoxifen-dependent Cre recombinase allow us to limit the problem of selectivity and embryonic expression of Cre, respectively. Indeed, we found that Cre-mediated inactivation of Lpin1 leads to a multilocular adipocyte phenotype in both aP2-Cre lines and in MEFs derived from an aP2-Cre line, confirming the cell-autonomous specificity of the Lpin1 adipocyte phenotype.
Increased Lpin1 expression in either adipose tissue or skeletal muscle was previously demonstrated to promote obesity and to improve systemic insulin sensitivity (40) . Conversely, our data showed that mice with adipocyte-selective Lpin1 deficiency develop lipodystrophy and resistance to HFD-induced obesity. Although the resistance to obesity in aP2-Cre lines is likely related to the role of lipin 1 in triglyceride storage, the increased basal metabolic rate and total energy expenditure may also contribute to this phenotype (52) , in line with the previous observation that Lpin1 fld/fld mice exhibit higher oxygen consumption without alteration of food intake (40) . These phenotypes, although less severe than with Lpin1 fld/fld mice (45), were paralleled by insulin resistance. These in vivo studies thus confirmed that lower adipose lpin1 expression is detrimental for systemic insulin sensitivity. While the association between lipodystrophy and hyperinsulin- emia was previously established (44, 50) , the exact mechanism behind this phenomenon remains to be elucidated.
We further explored the consequences of Lpin1 inactivation in matures adipocytes. While the expression of lipin 1 recovered at D60 after Tamox injection, the reduced size of the adipocytes in aP2
Cre-ERT2/ϩ /Lp fEx2-3/fEx2-3 mice indicated that Lpin1-deficient adipocytes were replaced by newly differentiated adipocytes (Fig.  10A ). This possibility is consistent with the observation that aP2
Cre/ϩ /Lp fEx2-3/fEx2-3 WAT contains large numbers of proliferating cells compared to controls and that incorporated BrdU overlapped substantially with the multilocular adipocyte cell subpopulation. In addition, we found that the mRNA level of Wisp2, an adipocyte precursor cell marker (8, 47) , was increased at D7 in aP2
Cre-ERT2/ϩ /Lp fEx2-3/fEx2-3 WAT. These findings suggest that the origin of the newly differentiated adipocytes may be either a preadipocyte or multipotent stem cell pool, which is not Lpin1 ablated (3, 7, 48) . It was previously suggested that the reduced adipocyte size plays a protective role in HFD-induced obesity. Also, adipose tissue inflammation was previously correlated with hepatic steatosis (5) . In agreement with these findings, our data indicate that adipose tissue macrophage accumulation is proportional to the size of adipocytes, thus supporting the "adipose tissue expandability" hypothesis (58, 60) . During HFD feeding conditions, the adipocyte tissue storage capacity or "expandability" was reached in control aP2 ϩ/ϩ /Lp fEx2-3/fEx2-3 mice and triggered adipocyte macrophage infiltration and lipid accumulation in the liver (Fig. 10A) . However, the presence of smaller adipocytes in aP2
Cre-ERT2/ϩ / Lp fEx2-3/fEx2-3 mice provided them with larger "expandability," thus contributing to observed protection against macrophage accumulation and hepatic steatosis. Together, these results suggest that pharmacological modulation of PAP1/lipin 1 activity (potentially leading to partial elimination of mature adipocytes) could be used as a strategy for prevention of obesity.
While both adipogenesis and lipogenesis are affected in Lpin fld/fld mice (43, 45) , the integrity of adipose tissue was preserved in aP2
Cre/ϩ /Lp fEx2-3/fEx2-3 mice, and only lipid storage was affected. Part of this difference may be the consequence of the timing of aP2
Cre -driven expression (19, 23, 49 ocular adipocytes with numerous small lipid droplets (typical structure of brown adipocytes), and a minority of them expressed UCP1 (21). We did not observe the expression of UCP1 (see Fig.  S3 in the supplemental material), suggesting that the multilocular aP2
Cre/ϩ /Lp fEx2-3/fEx2-3 phenotype may result from dysregulation of lipolysis. However, the level of mRNA expression of HSL and ATGL, which are enzymes involved in triacylglycerol hydrolysis in adipocytes, was decreased when Lpin1 was inactivated in adipocytes. These results suggest that the reduced accumulation of lipids/multilocular phenotype induced by Lpin1 inactivation is mediated by an as yet unknown mechanism independent of HSL and ATGL action.
We detected large amounts of PA (the PAP1 enzyme substrate) in the white adipose tissue of Lpin1 fld/fld (36) , rat Lpin1 1hubr (34) , and adipocyte-selective Lpin1 knockout mice (this study). This is of interest, since we previously observed that PA mediates demyelination in Schwann cell-specific Lpin1 knockout mice (36) . PA is an important lipid mediator in signal transduction of many pathways, including the mTOR and MEK-Erk pathways (2, 16) . We observed, similar to the situation in Schwann cells, that PA inhibits adipocyte differentiation via the MEK-Erk pathway. This pathway was previously shown to have a dual role in adipogenesis: its activation is crucial for the early proliferative stage of adipogenesis, but the subsequent downregulation of this pathway is required for terminal adipocyte differentiation (4, 65) . In contrast to what was observed in peripheral nerve tissue, PA did not affect mature adipocyte maintenance (see Fig. S8 in the supplemental material). These results thus suggest that the inhibitory effect of PA occurs mainly at an early stage of adipocyte differentiation, which may explain in part the difference between the Lpin1 fld/fld and aP2
Cre/ϩ /Lp fEx2-3/fEx2-3 adipocyte phenotypes, since Lpin1 inactivation (and consequently PA accumulation) occurs at a later developmental stage in aP2
Cre/ϩ /Lp fEx2-3/fEx2-3 mice. Together, these observations are in favor of the hypothesis that after adipocyte development, lipin 1 predominantly plays a role in its progressive accumulation of lipids (mediated through its role in TAG biosynthesis [ Fig. 10B] ) and thus in maintenance of its "unilocular" phenotype. When Lpin1 is inactivated in aP2
Cre/ϩ /Lp fEx2-3/fEx2-3 or aP2
Cre-ERT2/ϩ /Lp fEx2-3/fEx2-3 mice, adipocytes "deflate" because their lipin 1-mediated capacity to accumulate lipids is negatively affected. Subsequently they die, to be progressively replaced by new adipocytes generated from the pool of adipocyte precursor cells.
One possible mechanism of how PA affects adipocyte development could be through its extracellular conversion to lysophosphatidic acid (LPA). LPA is known as a potent bioactive phospholipid that is able to regulate a number of cellular events, including adipogenesis (51). However, our experiments using pertussis toxin, an inhibitor of the G i/o protein-coupled LPA receptors, and propranolol, a lipin 1/PAP1 inhibitor, indicate that the observed adipocyte lipid storage defect in aP2
Cre/ϩ /Lp fEx2-3/fEx2-3 knockout mice is a consequence of intra-adipocyte PA accumulation (Fig. 10B) .
A very striking phenotype present in both aP2
Cre/ϩ /Lp fEx2-3/fEx2-3
and aP2
Cre-ERT2/ϩ /Lp fEx2-3/fEx2-3 mice was the alteration of iBAT structure and function. The primary defects in iBAT were the loss of weight and the reduced expression of Ucp1, PGC-1␣, PPAR␣, and various enzymes of the ␤-oxidation (Acox1, Cpt1b, Acsl1, and Acadm). We further showed that mice lacking lipin 1 are cold sensitive. These results are compatible with previous reports showing that the activation of PPAR␣ leads to specific induction of genes involved in ␤-oxidation (12) and that lipin 1 activates fatty acid ␤-oxidation by inducing PPAR␣ expression in the liver (15) . Interestingly, we observed that thermogenic activation induces Lpin1 gene expression. Thus, the impaired thermogenesis function in the absence of lipin 1 is likely explained by the compromised transcriptional induction of PPAR␣, PGC-1␣, and consecutively UCP1. Together, these results revealed an unexpected role of lipin 1 in iBAT maintenance and function.
Lipin 1 has emerged as a crucial player in lipid metabolism, and the variation in its function was associated with both lipodystrophy and obesity (42) . Herein, we demonstrated that adipocyte cell autonomous disruption of lipin 1 prevents adipocyte maturation, and we revealed the physiological relevance of the antiadipogenic activity of PA. While our data provide important insight into the relationship between defective triglyceride synthesis and lipodystrophy in the presented experimental paradigms, further experiments are needed to clarify how effectively these results replicate the etiology of human lipodystrophy. Our observation that cell autonomous inactivation of lipin 1 in mature adipocytes affects their survival and lipid accumulation strengthens the idea that adipocyte-selective lipin 1 modulation may constitute an appropriate target aiming at the prevention of metabolic disturbances in the context of obesity. Nonetheless, the adverse consequences of lipin 1 inhibition should be considered in regard to its pivotal role in other tissues, especially skeletal muscle (33, 64) and peripheral nervous system development and function (36) .
